Chromatographic comparison of atenolol separation in reaction media on cellulose tris-(3,5-dimethylphenylcarbamate) chiral stationary phase using ultra fast liquid chromatography

Chirality

Volumn 24, Issue 5, 2012, Pages 356-367

  Agustian, Joni ^a,b   Kamaruddin, Azlina Harun ^a   Aboul Enein, Hassan Y ^c  

^a SCHOOL OF PHYSICS   (Malaysia)

^b UNIVERSITY OF LAMPUNG   (Indonesia)

^c NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

analytical protocol; buffers media; Chiralcel OD Column; enantiomers separation; organic; racemic atenolol

Indexed keywords

ALCOHOL; ATENOLOL; CELLULOSE TRIS(3,5 DIMETHYLPHENYLCARBAMATE); SOLVENT;

ANALYTIC METHOD; ARTICLE; CHIRALITY; CONTROLLED STUDY; ENANTIOMER; ENANTIOSELECTIVITY; FLOW RATE; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; RACEMIZATION; ULTRA FAST LIQUID CHROMATOGRAPHY; ULTRAVIOLET RADIATION;

ACETYLATION; ATENOLOL; CELLULOSE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, LIQUID; LIPASE; PHENYLCARBAMATES; SOLVENTS; STEREOISOMERISM;

EID: 84860442613     PISSN: 08990042     EISSN: 1520636X     Source Type: Journal    
DOI: 10.1002/chir.22019     Document Type: Article

References (59)

1. Anroop B, Ghosh B, Parcha V, Kumar A, Khanam J,. Synthesis and comparative skin permeability of atenolol and propranolol esters. J Drug Del Sci Tech 2005; 15 (2): 187-190. (Pubitemid 40477984)
2. Mehta SR, Bhawal BM, Deshpande VH, Gurjar MK,. Process for producing atenolol of high optical purity. US Patent US 6,982,349B1. 2006.01.03.
3. Sneader W,. Drug discovery: a history. Chichester: John Willey & Sons; 2005. p 468.
4. Westfall TC, Westfall DP,. Adrenergic agonists and antagonists. In:, Brunton LL, Lazo JS, Parker KL, editors. Goodman and Gilman's the pharmacological basis of therapeutics, 11th ed. NewYork: McGraw-Hill; 2006. p 271-295.
5. Hara T,. Innovations in the pharmaceuticals industry: the process of drug discovery and development. Cheltenham: Edward Elgar Publishing Limited; 2003. p 271.
6. Stoschitzky K, Egginger G, Zernig G, Kelin W, Lindner W,. Stereoselective features of (R) and (S)-atenolol: clinical pharmacological, pharmacokinetic, and radio ligand binding studies. Chirality 1993; 5: 15-19. (Pubitemid 23123045)
7. McCoy RA, Clifton GD, Clementi WA, Smith MD, Garvey TQ, Wermeling DP, Schwartz SE,. Pharmacodynamics of racemic and S(-)-atenolol in humans. J Clin Pharmacol 1994; 34: 816-822. (Pubitemid 24325008)
8. Kumar A, Vyas KD, Singh D, Mahale GD, Nellithanath TB, Nandavadekar S, Jadhav BG, Saxena AKNK, Dharji MK, Bhattacharya A, Lakhera A,. Novel diasteriomeric salts of atenolol and their use in the production of optically active atenolol. WIPO Patent WO 2006/046252 A2. 2006.05.04.
9. Stoschitzky K, Lindner W, Kiowski W,. Stereoselective vascular effects of the (R)- and (S)-enantiomers of propranolol and atenolol. J Cardiovasc Pharmacol 1995a; 25: 268-272.
10. Stoschitzky K, Kahr S, Donnerer J, Schumacher M, Luha O, Maier R, Klein W, Lindner W,. Stereoselective increase of plasma concentrations of the enantiomers of propranolol and atenolol during exercise. Clin Pharmacol Ther 1995b; 57: 543-551.
11. Ali I, Al-Othman ZA, Hussain A, Saleem K, Aboul-Enein HY,. Chiral separation of β-adrenergic blockers in human plasma by SPE-HPLC. Chromatographia 2011; 73: 251-256.
12. Chiral Emcure Pharmaceutical Ltd. Chirality: what is chirality. downloaded on July 11, 2011 from
13. Agustian J, Kamaruddin AH, Bhatia S,. Single enantiomeric β-blockers-the existing technologies. Proc Biochem 2010; 45: 1587-1604.
14. Zelaszczyk D, Kiec-Kononowicz K,. Biocatalytic approaches to optically active β-blockers. Curr Med Chem 2007; 14: 53-65. (Pubitemid 46050303)
15. Bose DS, Narsaiah AV,. An efficient asymmetric synthesis of (S)-atenolol: using hydrolytic kinetic resolution. Bioorg Med Chem 2005; 13: 627-630.
16. Kawthekar RB, Bi WT, Kim GJ,. Synthesis and application of bimetallic chiral [Co(salen)]-type complexes: a new catalytic approach to synthesis of optically pure β-blockers via kinetic resolution of epichlorohydrin. Appl Organometal Chem 2008; 22: 583-591.
17. Kawthekar RB, Kim GJ,. Enantioselective synthesis of β-blockers via hydrolytic kinetic resolution of terminal oxiranes by using bimetallic chiral {{2,2'-[Cyclohexane-1,2 diylbis (nitrilomethylidyne)] bis[phenolato]}(2-)} cobalt([Co(salen)])-Type Complexes. Helv Chim Acta 2008; 91: 317-332.
18. Kitaori K, Takehira Y, Furukawa Y, Yoshimoto H, Otera J,. A practical synthesis of optically active atenolol from chiral epichlorohydrin. Chem Pharm Bull 1997; 45 (2): 412-414. (Pubitemid 27131875)
19. Takehira Y, Saragai N, Kitaori K,. Process for producing optically active atenolol and intermediate thereof. US Patent US005,130,482A, 92.07.14 (1992).
20. Takehira Y, Saragai N, Kitaori K,. Process for producing optically active atenolol and intermediate thereof. US Patent US005,223,646A, 93.06.29 (1993).
21. Damle SV, Patil PN, Salunkh MS,. Biotransformation with Rhizopus arrhizus and Geothricum candidum for the preparation of (S)-atenolol and (S)-propranolol. Bioorg Med Chem 2000; 8: 2067-2070. (Pubitemid 30612497)
22. Damle SV, Patil PN, Salunkhe MM,. Chemoenzymatic synthesis of (R)- and (S)-atenolol and propranolol employing lipase catalysed enantioselective esterification and hydrolysis. Synth Comm 1999; 29 (22): 3855-3862. (Pubitemid 29441516)
23. Barbosa O, Ortiz C, Torresa R, Fernandez-Lafuente R,. Effect of the immobilization protocol on the properties of lipase B from Candida antarctica in organic media: enantiospecific production of atenolol acetate. J Mol Cat B: Enzymatic 2011; 71: 124-132.
24. Ali I, Gaitonde VD, Aboul-Enein HY, Hussain A,. Chiral separation of β-adrenergic blockers on CelluCoat column by HPLC. Talanta 2009; 78: 458-463.
25. Aboul-Enein HY, Ali I,. Studies on the effect of alcohols on the chiral discrimination mechanisms of amylose stationary phase on the enantioseparation of nebivolol by HPLC. J Biochem Biophys Methods 2001a; 48: 175-188. (Pubitemid 32455455)
26. Aboul-Enein HY, Ali I,. HPLC Enantiomeric resolution of nebivolol on normal and reversed amylose based chiral phases. Pharmazie 2001b; 56: 214-216. (Pubitemid 32209945)
27. Bhushan R, Tanwar S,. Direct TLC resolution of atenolol and propranolol into their enantiomers using three different chiral selectors as impregnating reagents. Biomed Chromatogr 2008; 22: 1028-1034.
28. Bhushan R, Aora M,. Direct enantiomeric resolution of (±)-atenolol, (±)-metoprolol, and (±)-propranolol by impregnated TLC using l-aspartic acid as chiral selector. Biomed Chromatogr 2003; 17: 226-230. (Pubitemid 36818144)
29. Kim HK, Lee JH, Ko MY, Hong SP, Youm JR,. Chiral separation of β-blockers after derivatization with (-)-α-methoxy-α- (trifluoromethyl)phenylacetyl chloride by gas chromatography. Arch Pharm Res 2001; 24 (5): 402-406. (Pubitemid 33647257)
30. Mikuldas H, Cepanec I, Sporec A, Litvic M, Vinkovic V,. Use of enantioselective liquid chromatography for preparation of pure atenolol enantiomers. J Sep Sci 2005; 28: 251-256. (Pubitemid 40439605)
31. Santoro MI, Cho HS, Kedor-Hackmann ER,. Enantiomeric separation and quantitative determination of atenolol in tablets by chiral high-performance liquid chromatography. Drug Dev Ind Pharm 2000; 26 (10): 1107-1110.
32. Ali I, Saleem K, Gaitonde VD, Aboul-Enein HY, Hussain I,. Chiral separations of some β-adrenergic agonists and antagonists on AmyCoat column by HPLC. Chirality 2010; 22: 24-28.
33. Herbert Knauer GmbH. Applications journal V01/2011. Downloaded on Sunday 28 August 2011 from
34. Regis Technologies Inc. Atenolol. Downloaded on Sunday 28 August 2011 from: Applications/ChiralApplications/atenolol.html
35. Regis Technologies Inc. Regis chiral user's guide. Downloaded on Sunday 28 August 2011 from
36. Torul H, Tamer U,. Determination of enantiomers of atenolol and propranolol in pharmaceutical formulations by HPLC. JAOAC Int 2011; 94 (3): 833-838.
37. Phenomenex Inc. Applications: atenolol. Downloaded on Sunday 28 August 2011 from
38. Deeb SE,. Evaluation of a vancomycin-based LC column in enantiomeric separation of atenolol: method development, repeatability study and enantiomeric impurity determination. Chromatographia 2010; 71: 783-787.
39. Shimadzu (Asia Pacific) Pte. Ltd. LCsolution operation guide (basic). Singapore: Shimadzu (Asia Pacific) Pte. Ltd.; 2009. p. 21.
40. Ekelund J, Arkens AV, Bronnum-Hansen K, Fich K, Olsen L, Petersen PV,. Chiral separation of β-blocking drug substances using chiral stationary phases. J Chromatogr A 1995; 708: 253-261.
41. Singh AK, Kedor-Hackmann ERM, Santoro MIRM,. Development and validation of a chiral liquid chromatographic method for the determination of atenolol and metoprolol enantiomers in tablet preparations. J AOAC Int 2001; 84 (6): 1724-1729. (Pubitemid 33615050)
42. Daicel Chemical Industries, Ltd. Instruction manual for chiral HPLC columns: Chiralcel® OD < Analytical Column>. Osaka: Daicel Chemical Industries Ltd.; 2009. p 2.
43. Chiral technologies Europe. Instruction manual for Chiralcel® OD columns. Cedex: Chiral Technologies Europe; 2003. p 4.
44. Fazlena H, Kamaruddin AH, Zulkali MMD,. Dynamic kinetic resolution: alternative approach in optimizing S-ibuprofen production. Bioproc Biosys Eng 2006; 28: 227-233. (Pubitemid 43333973)
45. Adamczak M, Krishna SH,. Strategies for improving enzymes for efficient biocatalysis. Food Technol Biotechnol 2004; 42 (4): 251-264. (Pubitemid 40044640)
46. Baudequin C, Bregeon D, Levillain J, Guillen F, Plaquevent JC, Gaumont AC,. Chiral ionic liquids, a renewal for the chemistry of chiral solvents? Design, synthesis and applications for chiral recognition and asymmetric synthesis. Tetrahedron: Asymmetry 2005; 16: 3921-3945. (Pubitemid 41773070)
47. Welch CJ,. Chiral chromatography in support of pharmaceutical process research. In:, Cox GB,. editor. Preparative enantioselective chromatography. Oxford: Blackwell publishing; 2005. p 1-18.
48. WHO Pharmacopoeia Library. Monographs: pharmaceutical substances: atenololum-atenolol. downloaded on Monday 05 September 2011 from: phint/en/p/docf/
49. Teva Pharmaceutical Industries Ltd. Atenolol. downloaded on Monday 05 September 2011 from
50. Agustian J, Kamaruddin AH, Bhatia S,. Enzymatic membrane reactors: the determining factors in two separate phase operations. J Chem Technol Biotechnol 2011; 86: 1032-1048.
51. Schmid MG, Gecse O, Szabo Z, Kilár F, Gübitz G, Ali I, Aboul-Enein HY,. Comparative study of the chiral resolution of β-blockers on cellulose tris (3,5-dimethylphenylcarbamate) phases in normal and reversed phase modes. J Liq Chrom & Rel Technol 2001; 24 (16): 2493-2504. (Pubitemid 32937353)
52. Williams KL, Sander LC, Wise SA,. Comparison of liquid and supercritical fluid chromatography for the separation of enantiomers on chiral stationary phases. J Pharm Biomed Anal 1997; 15: 1789-1799. (Pubitemid 27308691)
53. Iha MH, Martinez AS, Bonato PS,. Enantioselective analysis of atenolol in biologic fluids: comparison of liquid-liquid and solid-phase extraction methods. J Chrom B 2002; 767: 1-9. (Pubitemid 34142329)
54. Navratilova H, Opatrilova R, Kriz Z, Koca J,. Enantioselective chromatography and molecular modelling of novel aryloxyaminopropan-2-ols with the alkyl carbamate function. Chirality 2004; 16: 139-146. (Pubitemid 38295842)
55. Ye KY, Stringham RW,. The effect of acidic and basic additives on the enantioseparation of basic drugs using polysaccharide-based chiral stationary phases. Chirality 2006; 18: 519-530. (Pubitemid 43946220)
56. Bidlingmeyer BA,. Practical HPLC: methodology and applications. New York: John Wiley & Sons; 1992. p 452.
57. Hanai T,. HPLC: a practical guide. Cambridge: The Royal Society of Chemistry; 1999. p 134.
58. Hintermann L,. Peak separation by adventitious or added water in normal-phase chiral HPLC. J Org Chem 2007; 72: 9790-9793. (Pubitemid 350231837)
59. Wikipedia. HPLC. downloaded on Monday 05 September 2011 from